IGSF4 methylation as an independent marker of human papillomavirus-positive oropharyngeal squamous cell carcinoma.
暂无分享,去创建一个
G. Divine | M. Worsham | J. K. Stephen | K. Chen | M. Mahan | S. Havard | J. Stephen
[1] G. Gardner,et al. Delineating an epigenetic continuum in head and neck cancer. , 2014, Cancer letters.
[2] G. Divine,et al. HPV and methylation indicators in paired tumor and saliva in HNSCC , 2013 .
[3] G. Divine,et al. Epigenetic Modulation of Signal Transduction Pathways in HPV-Associated HNSCC , 2013, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[4] Christopher R. Schmidt,et al. HPV-related methylation signature predicts survival in oropharyngeal squamous cell carcinomas. , 2013, The Journal of clinical investigation.
[5] G. Divine,et al. Improved Survival with HPV among African Americans with Oropharyngeal Cancer , 2013, Clinical Cancer Research.
[6] Tim Fenton,et al. Identification and functional validation of HPV-mediated hypermethylation in head and neck squamous cell carcinoma , 2013, Genome Medicine.
[7] R. Shaw,et al. The epigenetic landscape of oral squamous cell carcinoma , 2013, British Journal of Cancer.
[8] G. Divine,et al. Significance of p16 in Site-specific HPV Positive and HPV Negative Head and Neck Squamous Cell Carcinoma. , 2012, Cancer and clinical oncology.
[9] K. Ang,et al. Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] G. Gardner,et al. Human Papillomavirus Outcomes in an Access-to-Care Laryngeal Cancer Cohort , 2012, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[11] G. Mills,et al. Downregulation of SMG-1 in HPV-Positive Head and Neck Squamous Cell Carcinoma Due to Promoter Hypermethylation Correlates with Improved Survival , 2012, Clinical Cancer Research.
[12] Esther Kim,et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] Maureen A Sartor,et al. Genome-wide methylation and expression differences in HPV(+) and HPV(-) squamous cell carcinoma cell lines are consistent with divergent mechanisms of carcinogenesis , 2011, Epigenetics.
[14] Steven S. Chang,et al. Detection of Promoter Hypermethylation in Salivary Rinses as a Biomarker for Head and Neck Squamous Cell Carcinoma Surveillance , 2011, Clinical Cancer Research.
[15] W. Thorstad,et al. Human papillomavirus-related squamous cell carcinoma of the oropharynx: a comparative study in whites and African Americans. , 2011, Archives of otolaryngology--head & neck surgery.
[16] Gypsyamber D'Souza,et al. HPV-associated head and neck cancer: a virus-related cancer epidemic. , 2010, The Lancet. Oncology.
[17] S. Lippman,et al. Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC) , 2010, Head & neck oncology.
[18] M. Suntharalingam,et al. Racial Survival Disparity in Head and Neck Cancer Results from Low Prevalence of Human Papillomavirus Infection in Black Oropharyngeal Cancer Patients , 2009, Cancer Prevention Research.
[19] Alyce A. Chen,et al. Genetic variation in the vitamin C transporter, SLC23A2, modifies the risk of HPV16-associated head and neck cancer. , 2009, Carcinogenesis.
[20] R. Shaw,et al. The role of pyrosequencing in head and neck cancer epigenetics: correlation of quantitative methylation data with gene expression. , 2008, Archives of otolaryngology--head & neck surgery.
[21] K. Gustafson,et al. Quantitative methylation‐specific PCR for the detection of aberrant DNA methylation in liquid‐based Pap tests , 2008, Cancer.
[22] A. Cmelak,et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. , 2008, Journal of the National Cancer Institute.
[23] S. Sethi,et al. Methylation of multiple genes as diagnostic and therapeutic markers in primary head and neck squamous cell carcinoma. , 2007, Archives of otolaryngology--head & neck surgery.
[24] Carole Fakhry,et al. Case-control study of human papillomavirus and oropharyngeal cancer. , 2007, The New England journal of medicine.
[25] T. Kouzarides,et al. Viral oncoproteins target the DNA methyltransferases , 2007, Oncogene.
[26] H. Boezen,et al. Assessment of gene promoter hypermethylation for detection of cervical neoplasia , 2006, International journal of cancer.
[27] J. Schouten,et al. Epigenetic events of disease progression in head and neck squamous cell carcinoma. , 2006, Archives of otolaryngology--head & neck surgery.
[28] J. Schouten,et al. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma. , 2006, Archives of otolaryngology--head & neck surgery.
[29] S. Rogers,et al. Promoter methylation of P16, RARβ, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing , 2006, British Journal of Cancer.
[30] S. Franceschi,et al. Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review , 2005, Cancer Epidemiology Biomarkers & Prevention.
[31] M. Gillison,et al. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. , 2004, Seminars in oncology.
[32] R. Weber,et al. Differential Methylation Status of Tumor-Associated Genes in Head and Neck Squamous Carcinoma , 2004, Clinical Cancer Research.
[33] D. Lowy,et al. A causal role for human papillomavirus in head and neck cancer , 2004, The Lancet.
[34] C. Meijer,et al. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia. , 2004, Journal of the National Cancer Institute.
[35] J. Schouten,et al. Delineating genetic pathways of disease progression in head and neck squamous cell carcinoma. , 2003, Archives of otolaryngology--head & neck surgery.
[36] S. Goodman,et al. Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[37] David Sidransky,et al. Emerging molecular markers of cancer , 2002, Nature Reviews Cancer.
[38] H. Fukuhara,et al. TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer , 2001, Nature Genetics.
[39] D. Sidransky,et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. , 2000, Journal of the National Cancer Institute.
[40] P. Laird,et al. MethyLight: a high-throughput assay to measure DNA methylation. , 2000, Nucleic acids research.
[41] Y. Lo,et al. Quantitative analysis of aberrant p16 methylation using real-time quantitative methylation-specific polymerase chain reaction. , 1999, Cancer research.
[42] P Hunt,et al. Localization of tumor suppressor activity important in nonsmall cell lung carcinoma on chromosome 11q. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[43] G. Slade,et al. National prevalence of oral HPV infection and related risk factors in the US adult population reply. , 2013, Oral diseases.
[44] J. Stockman. Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer , 2012 .
[45] 伊藤 鉄夫. Involvement of TSLC1 in progression of esophageal squamous cell carcinoma , 2005 .